Program
In-person AND virtual! – We are pioneering a new conference format that will connect in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR is pushing the boundaries
of innovation to design an event that works in today’s quickly changing environment.
In-person registration included the full virtual experience, and virtual-only attendees will be able to tune into live in-person sessions and/or
watch captured in-person sessions on-demand in addition to having a variety of virtual-only sessions to attend.
How Can We Make the Study of Patient Preferences More Useful to Decision-Makers in Health? The Final Recommendations from the ISPOR Using Patient Preferences to Inform Decision Making Good Practices Task Force
Speaker(s)
Moderator: John F P Bridges, PhD, Department of Biomedical Informatics and Surgery, Ohio State University College of Medicine, Columbus, OH, USA
Speakers: Deborah Marshall, PhD, BSc, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Sebastian Heidenreich, MSc, PhD, Evidera, London, LON, UK; Laura Lee Johnson, PhD, CDER, Food and Drug Administration, Silver Spring, MD, USA
Presentation Documents
The framework spans 5 domains for conducting patient preference studies to increase the use and relevance of these studies to decision makers: i. The context – A complete understanding of how decision makers function, how decisions are made, and how studies on patient preferences may be received and used. ii. The purpose – A clear articulation of how the study on patient preferences responds to decision makers’ needs and how the findings are expected to inform decision making. iii. The population – A thorough consideration of who the findings of the study will be applied to (directly or indirectly) and the intended and unintended consequences for those people. iv. The method – A selection of method/s to study patient preferences that reflects the needs, wants, and capabilities of decision makers, patients, and other stakeholders. v. The impact – A proactive effort both to ensure that the study findings can inform decision making and to measure if and how they influenced decision makers and decision-making.
Speakers will discuss: 1) a detailed overview of the ISPOR Framework; 2) compare it to different preference elicitation methods’ frameworks/recommendations such as IMI PREFER; 3) it’s application to a decision-relevant case study and 4) the decision-maker’s perspective. Feedback on bridging the gap between methods and applications will be part of the polling and moderated Q&A session.
Code
232